(Q36710138)

15 August 2017

1 reference

title

Medical therapy in adults with fibrous dysplasia of bone (English)

1 reference

15 August 2017

Roland D Chapurlat

1

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Journal of Bone and Mineral Research

15 August 2017

published in

1 reference

15 August 2017

volume

21 Suppl 2

1 reference

15 August 2017

page(s)

P114-9

1 reference

Activating mutations of the stimulatory G protein in the McCune-Albright syndrome

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Oral alendronate treatment for polyostotic fibrous dysplasia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S222

21 January 2018

Identifiers

DOI

10.1359/JBMR.06S222

1 reference

15 August 2017

1 reference